IPO Calendar
Lead Manager
- J P Morgan Chase (490)
- Goldman Sachs (463)
- Morgan Stanley (421)
- Bank of America Merrill Lynch (358)
- Citigroup (222)
- Jefferies (214)
- Credit Suisse (180)
- Barclays (151)
- Cowen and Company (147)
- Deutsche Bank (84)
- Leerink Partners (70)
- Piper Jaffray (70)
- Stifel (65)
- UBS Investment Bank (53)
- Evercore (52)
- RBC Capital (51)
- BMO Capital (49)
- Wells Fargo (47)
- Raymond James (38)
- William Blair (37)
More +
IPO - Pricing (9)
Cowen and Company
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 2 | Allena Pharmace | Health-Care | 14 | 5 | CS | JEFF | COWN | 45.1% | -28.7% | ||
| Nov 2 | Spero Therapeut | Health-Care | 14 | 5 | BAML | COWN | Stifel | 40.5% | -17.9% | ||
| Sep 28 | NuCana plc | Health-Care | 15 | 6 | CITI | JEFF | COWN | 27.9% | 7.7% | ||
| Jun 28 | Mersana Therape | Health-Care | 15 | 5 | JPM | COWN | LRNK | 54% | -6.7% | ||
| May 17 | G1 Therapeutics | Health-Care | 15 | 7 | JPM | COWN | 38.7% | 0% | |||
| May 10 | Rhythm Pharmace | Health-Care | 17 | 7 | MS | BAML | COWN | 98.3% | 76.5% | ||
| May 5 | Ovid Therapeuti | Health-Care | 15 | 5 | CITI | COWN | 31.8% | -18.3% | |||
| Apr 5 | UroGen Pharma L | Health-Care | 13 | 4 | JEFF | COWN | 31.3% | 7.5% | |||
| Jan 27 | Jounce Therapeu | Health-Care | 16 | 6 | JPM | COWN | 66% | 7.8% | |||
*
Lead manager or one of top three managers in an underwriting team.